Pliant Therapeutics
Pliant Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of integrin-based therapies for underserved areas of medical need. Leveraging a proprietary integrin drug discovery and delivery platform, its lead program PLN-101095 is a dual-selective avb8/avb1 integrin inhibitor being evaluated in the FORTIFY clinical trial for patients with advanced or metastatic solid tumors, alongside additional pipeline programs in fibrosis and oncology. The company was surfaced as a portfolio company of Menlo Ventures and added to the API Evangelist network. As a clinical-stage pharmaceutical company, Pliant Therapeutics publishes no public developer API, SDK, or API documentation surface; this profile captures corporate identity and web presence only.
Pliant Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Pharmaceuticals, Biotechnology, and Healthcare.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 3
The organization behind the API